Literature DB >> 2029210

Investigation and management of gout in the young and the elderly.

P A Dieppe1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2029210      PMCID： PMC1004400          DOI： 10.1136/ard.50.4.263

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  18 in total

1.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

2.  Diversity of clinical features in gouty arthritis.

Authors:  T F Yu
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

3.  Precocious familial gout with reduced fractional urate clearance and normal purine enzymes.

Authors:  G Calabrese; H A Simmonds; J S Cameron; P M Davies
Journal:  Q J Med       Date:  1990-05

4.  Nonarticular gout: hyperuricemia and tophus formation without gouty arthritis.

Authors:  P Hollingworth; J T Scott; H C Burry
Journal:  Arthritis Rheum       Date:  1983-01

5.  Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome.

Authors:  N I Abdou
Journal:  Arthritis Rheum       Date:  1983-08

6.  Diuretic-induced gout in elderly women.

Authors:  D G Macfarlane; P A Dieppe
Journal:  Br J Rheumatol       Date:  1985-05

7.  Familial gout and renal failure in young women.

Authors:  H A Simmonds; D J Warren; J S Cameron; C F Potter; D A Farebrother
Journal:  Clin Nephrol       Date:  1980-10       Impact factor: 0.975

8.  Familial occurrence of hyperuricemia, gout, and medullary cystic disease.

Authors:  G R Thompson; J J Weiss; R T Goldman; G A Rigg
Journal:  Arch Intern Med       Date:  1978-11

9.  Hypertension, renal function and gout.

Authors:  T Gibson; J Highton; H A Simmonds; C F Potter
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

10.  Limited value of uric acid to creatinine ratios in estimating uric acid excretion.

Authors:  R L Wortmann; I H Fox
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391
View more
  9 in total

1.  Missed opportunity following diagnosis of gout.

Authors:  S O'Reilly; M Doherty
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

Review 2.  Pathophysiology, clinical presentation and treatment of gout.

Authors:  Gim Gee Teng; Raj Nair; Kenneth G Saag
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Management of gout in older adults: barriers to optimal control.

Authors:  Karl T Hoskison; Robert L Wortmann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 4.  Clinical and biochemical aspects of uric acid overproduction.

Authors:  J García Puig; F A Mateos
Journal:  Pharm World Sci       Date:  1994-04-15

Review 5.  Optimal management of gout in older patients.

Authors:  E B Gonzalez; S B Miller; C A Agudelo
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

Review 6.  Management of hyperuricemia in gout: focus on febuxostat.

Authors:  Mattheus K Reinders; Tim L Th A Jansen
Journal:  Clin Interv Aging       Date:  2010-02-02       Impact factor: 4.458

Review 7.  Risks and benefits of drugs used in the management and prevention of gout.

Authors:  P G Conaghan; R O Day
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

8.  Clinical and family studies in Hungarian patients with gout.

Authors:  M Mituszova; A Judák; G Poór; E Gyódi; V Stenszky
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 9.  Gout in the elderly. Clinical presentation and treatment.

Authors:  A G Fam
Journal:  Drugs Aging       Date:  1998-09       Impact factor: 4.271
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.